New pill aims to stop kidney stones before they start
Disease control
Completed
This study tested an experimental drug called LLX-424 in 51 adults who have had kidney stones before. The drug works by blocking an enzyme that makes oxalate, a key ingredient in most kidney stones. Participants took the drug or a placebo daily for 8 weeks to see if it safely low…
Phase: PHASE2 • Sponsor: Lilac Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC